Cencora Defends Director’s Investigation of Alleged Syringe Scam

Pension funds sought Wednesday to undermine a single-member AmerisourceBergen Corp. board committee, whose findings pushed a Delaware court to dismiss litigation over a subsidiary’s alleged scheme to sell unsterile cancer medicines pooled from the overflow of pre-filled syringes.

The company is now known as Cencora Inc. The Delaware Chancery Court in November 2023 rejected the pension funds’ claims that the committee composed solely of former PricewaterhouseCoopers LLP chairman Dennis Nally had whitewashed the allegations.

Nally “took over a meritorious derivative claim involving serious misconduct, then unduly narrowed its investigation, excluded highly relevant evidence, and reached conclusions that are contradicted by ...